Introducing the AI Biosecurity Lab

Advances in AI are creating unprecedented opportunities for scientific discovery, but they are also changing the biological risk landscape. AI can accelerate research, improve our understanding of diseases, and support the discovery and development of new medical countermeasures. However, increasingly capable AI systems also create new biological risks and could lower barriers to harmful activity.

The UK is committed to harnessing the benefits of AI while strengthening resilience to biological threats. That’s why, as part of a National AI Biosecurity Initiative, the government is establishing the AI Biosecurity Lab (AIBL). 

The AI Biosecurity Lab will be the world’s first dedicated AI biosecurity organisation. Backed by £100 million of government funding, and up to £200 million in company commitments from OpenAI and Anthropic, it will develop technical capabilities that help the UK better understand, prevent, detect and respond to biological threats, building on the UK’s broader Biological Security Strategy.

AIBL will harness frontier AI to support partners, including the UK’s national biosecurity centres and world leading life sciences industry, to detect biological threats earlier and accelerate the discovery, development and testing of vaccines, treatments and other medical countermeasures, enabling the UK and the world to respond faster to disease outbreaks and strengthening resilience against future biological risks.

The AI Biosecurity Lab mission will be to strengthen our biosecurity by harnessing frontier AI. It will bring together frontier AI and biological science talent to develop practical technical capabilities that improve the UK’s ability to understand, prevent, detect and respond to biological threats.

AIBL’s cutting-edge research will strengthen UK and global resilience to a wide range of biological risks, including those enabled by advances in AI.

Initial delivery will focus on developing and deploying capabilities that: